{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:16:24Z","timestamp":1793225784873,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T00:00:00Z","timestamp":1722902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T00:00:00Z","timestamp":1722902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Institute of Child Health and Human Development","award":["5K12HD052896"],"award-info":[{"award-number":["5K12HD052896"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-68619-w","type":"journal-article","created":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T10:04:25Z","timestamp":1722938665000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Higher alpha diversity and Lactobacillus blooms are associated with better engraftment after fecal microbiota transplant in inflammatory bowel disease"],"prefix":"10.1038","volume":"14","author":[{"given":"Yanjia Jason","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athos","family":"Bousvaros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Docktor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abby L.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Rufo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"McKenzie","family":"Leier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madison","family":"Weatherly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori","family":"Zimmerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le Thanh Tu","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"Barton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J.","family":"Alm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacy A.","family":"Kahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,6]]},"reference":[{"key":"68619_CR1","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1053\/j.gastro.2021.01.010","volume":"160","author":"S Saha","year":"2021","unstructured":"Saha, S., Mara, K., Pardi, D. S. & Khanna, S. Long-term safety of fecal microbiota transplantation for recurrent Clostridioides difficile infection. Gastroenterology 160, 1961-1969.e3 (2021).","journal-title":"Gastroenterology"},{"key":"68619_CR2","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1053\/j.gastro.2020.09.038","volume":"160","author":"CR Kelly","year":"2021","unstructured":"Kelly, C. R. et al. Fecal microbiota transplantation is highly effective in real-world practice: Initial results from the FMT national registry. Gastroenterology 160, 183-192.e3 (2021).","journal-title":"Gastroenterology"},{"key":"68619_CR3","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.cgh.2019.04.037","volume":"18","author":"MR Nicholson","year":"2020","unstructured":"Nicholson, M. R. et al. Efficacy of fecal microbiota transplantation for clostridium difficile infection in children. Clin. Gastroenterol. H 18, 612-619.e1 (2020).","journal-title":"Clin. Gastroenterol. H"},{"key":"68619_CR4","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41575-019-0131-0","volume":"16","author":"G Cammarota","year":"2019","unstructured":"Cammarota, G. & Ianiro, G. FMT for ulcerative colitis: Closer to the turning point. Nat. Rev. Gastroenterol. 16, 266\u2013268 (2019).","journal-title":"Nat. Rev. Gastroenterol."},{"key":"68619_CR5","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/MIB.0000000000000975","volume":"23","author":"D Ishikawa","year":"2017","unstructured":"Ishikawa, D. et al. Changes in intestinal microbiota following combination therapy with fecal microbial transplantation and antibiotics for ulcerative colitis. Inflamm. Bowel Dis. 23, 116\u2013125 (2017).","journal-title":"Inflamm. Bowel Dis."},{"key":"68619_CR6","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s12876-021-01856-9","volume":"21","author":"JW Crothers","year":"2021","unstructured":"Crothers, J. W. et al. Daily, oral FMT for long-term maintenance therapy in ulcerative colitis: Results of a single-center, prospective, randomized pilot study. BMC Gastroenterol. 21, 281 (2021).","journal-title":"BMC Gastroenterol."},{"key":"68619_CR7","doi-asserted-by":"publisher","first-page":"e00975","DOI":"10.1128\/mBio.00975-21","volume":"12","author":"ND Chu","year":"2021","unstructured":"Chu, N. D. et al. Dynamic Colonization of microbes and their functions after fecal microbiota transplantation for inflammatory bowel disease. Mbio 12, e00975-e1021 (2021).","journal-title":"Mbio"},{"key":"68619_CR8","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1001\/jama.2018.20046","volume":"321","author":"SP Costello","year":"2019","unstructured":"Costello, S. P. et al. Effect of fecal microbiota transplantation on 8-week remission in patients with ulcerative colitis: A randomized clinical trial. Jama 321, 156 (2019).","journal-title":"Jama"},{"key":"68619_CR9","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1053\/j.gastro.2015.03.045","volume":"149","author":"NG Rossen","year":"2015","unstructured":"Rossen, N. G. et al. Findings from a randomized controlled trial of fecal transplantation for patients with ulcerative colitis. Gastroenterology 149, 110-118.e4 (2015).","journal-title":"Gastroenterology"},{"key":"68619_CR10","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1097\/MIB.0000000000000893","volume":"22","author":"BP Vaughn","year":"2016","unstructured":"Vaughn, B. P. et al. Increased intestinal microbial diversity following fecal microbiota transplant for active Crohn\u2019s disease. Inflamm. Bowel Dis. 22, 2182\u20132190 (2016).","journal-title":"Inflamm. Bowel Dis."},{"key":"68619_CR11","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1053\/j.gastro.2018.12.001","volume":"156","author":"S Paramsothy","year":"2019","unstructured":"Paramsothy, S. et al. Specific bacteria and metabolites associated with response to fecal microbiota transplantation in patients with ulcerative colitis. Gastroenterology 156, 1440-1454.e2 (2019).","journal-title":"Gastroenterology"},{"key":"68619_CR12","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.chom.2018.01.003","volume":"23","author":"CS Smillie","year":"2018","unstructured":"Smillie, C. S. et al. Strain tracking reveals the determinants of bacterial engraftment in the human gut following fecal microbiota transplantation. Cell Host Microbe 23, 229-240.e5 (2018).","journal-title":"Cell Host Microbe"},{"key":"68619_CR13","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1097\/MIB.0000000000001228","volume":"23","author":"N Narula","year":"2017","unstructured":"Narula, N. et al. Systematic review and meta-analysis. Inflamm. Bowel Dis. 23, 1702\u20131709 (2017).","journal-title":"Inflamm. Bowel Dis."},{"key":"68619_CR14","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1053\/j.gastro.2015.04.001","volume":"149","author":"P Moayyedi","year":"2015","unstructured":"Moayyedi, P. et al. Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial. Gastroenterology 149, 102-109.e6 (2015).","journal-title":"Gastroenterology"},{"key":"68619_CR15","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1093\/ecco-jcc\/jjx002.035","volume":"11","author":"S Costello","year":"2017","unstructured":"Costello, S. et al. OP036 Short duration, low intensity pooled faecal microbiota transplantation induces remission in patients with mild-moderately active ulcerative colitis: A randomised controlled trial. J. Crohn\u2019s Colitis 11, S23\u2013S23 (2017).","journal-title":"J. Crohn\u2019s Colitis"},{"key":"68619_CR16","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41575-021-00441-5","volume":"18","author":"C Danne","year":"2021","unstructured":"Danne, C., Rolhion, N. & Sokol, H. Recipient factors in faecal microbiota transplantation: One stool does not fit all. Nat. Rev. Gastroenterol. 18, 503\u2013513 (2021).","journal-title":"Nat. Rev. Gastroenterol."},{"key":"68619_CR17","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1097\/MPG.0000000000003336","volume":"74","author":"R Kellermayer","year":"2022","unstructured":"Kellermayer, R. et al. Fecal microbiota transplantation commonly failed in children with co-morbidities. J. Pediatr. Gastr. Nutr. 74, 227\u2013235 (2022).","journal-title":"J. Pediatr. Gastr. Nutr."},{"key":"68619_CR18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s40168-022-01251-w","volume":"10","author":"D Podlesny","year":"2022","unstructured":"Podlesny, D. et al. Metagenomic strain detection with SameStr: Identification of a persisting core gut microbiota transferable by fecal transplantation. Microbiome 10, 53 (2022).","journal-title":"Microbiome"},{"key":"68619_CR19","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1038\/s41591-022-01913-0","volume":"28","author":"TSB Schmidt","year":"2022","unstructured":"Schmidt, T. S. B. et al. Drivers and determinants of strain dynamics following fecal microbiota transplantation. Nat. Med. 28, 1902\u20131912 (2022).","journal-title":"Nat. Med."},{"key":"68619_CR20","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.copbio.2017.08.008","volume":"49","author":"J Walter","year":"2018","unstructured":"Walter, J., Maldonado-G\u00f3mez, M. X. & Mart\u00ednez, I. To engraft or not to engraft: An ecological framework for gut microbiome modulation with live microbes. Curr. Opin. Biotech. 49, 129\u2013139 (2018).","journal-title":"Curr. Opin. Biotech."},{"key":"68619_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100711","volume":"3","author":"D Podlesny","year":"2022","unstructured":"Podlesny, D. et al. Identification of clinical and ecological determinants of strain engraftment after fecal microbiota transplantation using metagenomics. Cell Rep. Med. 3, 100711 (2022).","journal-title":"Cell Rep. Med."},{"key":"68619_CR22","doi-asserted-by":"publisher","first-page":"e00905","DOI":"10.1128\/mSystems.00905-20","volume":"6","author":"C Haifer","year":"2021","unstructured":"Haifer, C. et al. Long-term bacterial and fungal dynamics following oral lyophilized fecal microbiota transplantation in Clostridioides difficile infection. Msystems 6, e00905-e920 (2021).","journal-title":"Msystems"},{"key":"68619_CR23","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13059-023-02924-x","volume":"24","author":"AR Watson","year":"2023","unstructured":"Watson, A. R. et al. Metabolic independence drives gut microbial colonization and resilience in health and disease. Genome Biol. 24, 78 (2023).","journal-title":"Genome Biol."},{"key":"68619_CR24","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1038\/s41591-022-01964-3","volume":"28","author":"G Ianiro","year":"2022","unstructured":"Ianiro, G. et al. Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases. Nat. Med. 28, 1913\u20131923 (2022).","journal-title":"Nat. Med."},{"key":"68619_CR25","doi-asserted-by":"publisher","first-page":"5517","DOI":"10.1038\/s41598-022-09307-5","volume":"12","author":"BJ Smith","year":"2022","unstructured":"Smith, B. J. et al. Strain-resolved analysis in a randomized trial of antibiotic pretreatment and maintenance dose delivery mode with fecal microbiota transplant for ulcerative colitis. Sci. Rep.-UK 12, 5517 (2022).","journal-title":"Sci. Rep.-UK"},{"key":"68619_CR26","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/mi.2016.123","volume":"10","author":"AH Keshteli","year":"2017","unstructured":"Keshteli, A. H., Millan, B. & Madsen, K. L. Pretreatment with antibiotics may enhance the efficacy of fecal microbiota transplantation in ulcerative colitis: A meta-analysis. Mucosal. Immunol. 10, 565\u2013566 (2017).","journal-title":"Mucosal. Immunol."},{"key":"68619_CR27","doi-asserted-by":"publisher","first-page":"2020067","DOI":"10.1080\/19490976.2021.2020067","volume":"14","author":"P Singh","year":"2022","unstructured":"Singh, P. et al. Effect of antibiotic pretreatment on bacterial engraftment after Fecal Microbiota Transplant (FMT) in IBS-D. Gut Microbes 14, 2020067 (2022).","journal-title":"Gut Microbes"},{"key":"68619_CR28","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/nmeth.1650","volume":"8","author":"D Knights","year":"2011","unstructured":"Knights, D. et al. Bayesian community-wide culture-independent microbial source tracking. Nat. Methods 8, 761\u2013763 (2011).","journal-title":"Nat. Methods"},{"key":"68619_CR29","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/apt.14387","volume":"47","author":"P Kump","year":"2018","unstructured":"Kump, P. et al. The taxonomic composition of the donor intestinal microbiota is a major factor influencing the efficacy of faecal microbiota transplantation in therapy refractory ulcerative colitis. Aliment. Pharm. Therap. 47, 67\u201377 (2018).","journal-title":"Aliment. Pharm. Therap."},{"key":"68619_CR30","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-035677","volume":"10","author":"KT Elvers","year":"2020","unstructured":"Elvers, K. T. et al. Antibiotic-induced changes in the human gut microbiota for the most commonly prescribed antibiotics in primary care in the UK: A systematic review. BMJ Open 10, e035677 (2020).","journal-title":"BMJ Open"},{"key":"68619_CR31","doi-asserted-by":"publisher","first-page":"1043971","DOI":"10.3389\/fcimb.2022.1043971","volume":"12","author":"L Xue","year":"2023","unstructured":"Xue, L. et al. Assessment of the impact of intravenous antibiotics treatment on gut microbiota in patients: Clinical data from pre-and post-cardiac surgery. Front. Cell. Infect. Microbiol. 12, 1043971 (2023).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"68619_CR32","doi-asserted-by":"publisher","first-page":"5617","DOI":"10.1038\/s41467-022-33313-w","volume":"13","author":"A Djukovic","year":"2022","unstructured":"Djukovic, A. et al. Lactobacillus supports Clostridiales to restrict gut colonization by multidrug-resistant Enterobacteriaceae. Nat. Commun. 13, 5617 (2022).","journal-title":"Nat. Commun."},{"key":"68619_CR33","doi-asserted-by":"publisher","first-page":"13758","DOI":"10.1021\/acs.jafc.9b06256","volume":"67","author":"S Xie","year":"2019","unstructured":"Xie, S. et al. Lactobacillus reuteri stimulates intestinal epithelial proliferation and induces differentiation into goblet cells in young chickens. J. Agric. Food Chem. 67, 13758\u201313766 (2019).","journal-title":"J. Agric. Food Chem."},{"key":"68619_CR34","doi-asserted-by":"publisher","first-page":"e01965-16","DOI":"10.1128\/mBio.01965-16","volume":"7","author":"C Staley","year":"2016","unstructured":"Staley, C., Kelly, C. R., Brandt, L. J., Khoruts, A. & Sadowsky, M. J. Complete microbiota engraftment is not essential for recovery from recurrent clostridium difficile infection following fecal microbiota transplantation. mBio 7, e01965-16 (2016).","journal-title":"mBio"},{"key":"68619_CR35","doi-asserted-by":"publisher","first-page":"e01586-19","DOI":"10.1128\/mBio.01586-19","volume":"10","author":"C Staley","year":"2019","unstructured":"Staley, C. et al. Durable long-term bacterial engraftment following encapsulated fecal microbiota transplantation to treat clostridium difficile infection. mBio 10, e01586-19 (2019).","journal-title":"mBio"},{"key":"68619_CR36","doi-asserted-by":"publisher","first-page":"4519","DOI":"10.1038\/s41598-021-84152-6","volume":"11","author":"C Staley","year":"2021","unstructured":"Staley, C. et al. Lower endoscopic delivery of freeze-dried intestinal microbiota results in more rapid and efficient engraftment than oral administration. Sci. Rep. 11, 4519 (2021).","journal-title":"Sci. Rep."},{"key":"68619_CR37","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.cell.2019.06.029","volume":"178","author":"CS Smillie","year":"2019","unstructured":"Smillie, C. S. et al. Intra- and inter-cellular rewiring of the human colon during ulcerative colitis. Cell 178, 714-730.e22 (2019).","journal-title":"Cell"},{"key":"68619_CR38","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1016\/S0140-6736(17)30182-4","volume":"389","author":"S Paramsothy","year":"2017","unstructured":"Paramsothy, S. et al. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: A randomised placebo-controlled trial. Lancet 389, 1218\u20131228 (2017).","journal-title":"Lancet"},{"key":"68619_CR39","doi-asserted-by":"publisher","first-page":"e00126","DOI":"10.1128\/mSphere.00126-19","volume":"4","author":"AM Seekatz","year":"2019","unstructured":"Seekatz, A. M. et al. Spatial and temporal analysis of the stomach and small-intestinal microbiota in fasted healthy humans. Msphere 4, e00126-e219 (2019).","journal-title":"Msphere"},{"key":"68619_CR40","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1080\/19490976.2016.1273998","volume":"8","author":"M Fischer","year":"2017","unstructured":"Fischer, M. et al. Fecal microbiota transplant in severe and severe-complicated Clostridium difficile: A promising treatment approach. Gut Microbes 8, 289\u2013302 (2017).","journal-title":"Gut Microbes"},{"key":"68619_CR41","first-page":"439","volume":"12","author":"JS Hyams","year":"1991","unstructured":"Hyams, J. S. et al. Development and validation of a pediatric Crohn\u2019s disease activity index. J. Pediatr. Gastroenterol. Nutr. 12, 439 (1991).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"68619_CR42","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1002\/ibd.20867","volume":"15","author":"D Turner","year":"2009","unstructured":"Turner, D. et al. Appraisal of the pediatric ulcerative colitis activity index PUCA. Inflamm. Bowel Dis. 15, 1218\u20131223 (2009).","journal-title":"Inflamm. Bowel Dis."},{"key":"68619_CR43","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/s41587-019-0209-9","volume":"37","author":"E Bolyen","year":"2019","unstructured":"Bolyen, E. et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat. Biotechnol. 37, 852\u2013857 (2019).","journal-title":"Nat. Biotechnol."},{"key":"68619_CR44","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nmeth.3869","volume":"13","author":"BJ Callahan","year":"2016","unstructured":"Callahan, B. J. et al. DADA2: High-resolution sample inference from Illumina amplicon data. Nat. Methods 13, 581\u2013583 (2016).","journal-title":"Nat. Methods"},{"key":"68619_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0061217","volume":"8","author":"PJ McMurdie","year":"2013","unstructured":"McMurdie, P. J. & Holmes, S. phyloseq: An R package for reproducible interactive analysis and graphics of microbiome census data. Plos One 8, e61217 (2013).","journal-title":"Plos One"},{"key":"68619_CR46","doi-asserted-by":"publisher","first-page":"7188","DOI":"10.1093\/nar\/gkm864","volume":"35","author":"E Pruesse","year":"2007","unstructured":"Pruesse, E. et al. SILVA: A comprehensive online resource for quality checked and aligned ribosomal RNA sequence data compatible with ARB. Nucleic Acids Res. 35, 7188\u20137196 (2007).","journal-title":"Nucleic Acids Res."},{"key":"68619_CR47","doi-asserted-by":"publisher","first-page":"3514","DOI":"10.1038\/s41467-020-17041-7","volume":"11","author":"H Lin","year":"2020","unstructured":"Lin, H. & Peddada, S. D. Analysis of compositions of microbiomes with bias correction. Nat. Commun. 11, 3514 (2020).","journal-title":"Nat. Commun."},{"key":"68619_CR48","doi-asserted-by":"crossref","unstructured":"Schulz KF, Altman DG & Moher D. for the CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials","DOI":"10.1016\/j.ijsu.2010.09.006"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-68619-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-68619-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-68619-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T10:11:19Z","timestamp":1722939079000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-68619-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,6]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["68619"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-68619-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,6]]},"assertion":[{"value":"18 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"AB receives research support as a subinvestigator on protocols for Janssen, Abbvie, Takeda, Buhlmann, Arena, Eli Lilly, Bristol Myers Squibb, PROCISE diagnostics. AB receives consulting revenue from Takeda, Best Doctors, Eli Lilly, and Fresenius Kabi. AB received an honorarium from Boston University and Royalties from Up To Date.  No other authors had any competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18188"}}